Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer

Published:2018-02 Issue:1 Volume:16 Page:e169-e172
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Poole Austin,Gill David,Hahn Andrew W.,Johnson Eric,Carroll Emma^ORCID,Boucher Kenneth,Nussenzveig Roberto,Maughan Benjamin,Agarwal Neeraj^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference19 articles.

1. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer;Scher;J Clin Oncol,1993

2. Prostate-specific antigen decline after Casodex withdrawal: evidence for an antiandrogen withdrawal syndrome;Small;Urology,1994

3. Antiandrogen withdrawal syndrome with nilutamide;Gomella;J Urol,1997

4. Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer;Figg;Am J Med,1995

5. Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426);Sartor;Cancer,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review;Cureus;2024-06-30

2. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley’s Toxin Revisited?;Cureus;2022-12-14

3. Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies;Cancers;2021-10-28

4. Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer;Endocrine-Related Cancer;2021-08-01

5. PSA response to antiandrogen withdrawal: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2021-02-18